Adimmune Corp (國光生技) on Thursday said it is developing a COVID-19 vaccine in cooperation with the National Health Research Institutes, and plans to run animal tests in the second quarter if its research proceeds smoothly.
The Taichung-based firm has been working to develop the vaccine utilizing its recombinant protein technology since acquiring a genetic sequence from the US Centers for Disease Control last month, Adimmune spokesman Pan Fei (潘飛) told the Taipei Times by telephone.
As the virus’ sequence reportedly evolves and appears different in separate regions, the company is attempting to determine whether the difference is considerable enough to affect the efficacy of a vaccine, Pan said.
“Though the novel coronavirus’ genetic sequence is 70 percent similar to that of the SARS virus, it is still not easy to make the vaccine,” he said.
Earlier this month National Taiwan University managed to isolate the virus strain of COVID-19, and Medigen Vaccine Biologics Corp (高端疫苗) on Monday said that it expects to conduct clinical tests for its vaccine in the second half of this year.
Adimmune would not use the isolated virus strain during its development to protect the safety of its research team, Pan said, adding that it is hard to forecast when it would enter the human trial stage
The Central Epidemic Command Center on Thursday said that an infected Taiwanese businessman returning from Zhejiang Province in China last month had antibodies against the virus in his blood.
However, Adimmune said that those antibodies would not help in the development of vaccines.
“Antibodies are created by patients’ immune systems. However, our goal is to produce an antigen against the virus, which is different,” Pan said.
Vincent Wei led fellow Singaporean farmers around an empty Malaysian plot, laying out plans for a greenhouse and rows of leafy vegetables. What he pitched was not just space for crops, but a lifeline for growers struggling to make ends meet in a city-state with high prices and little vacant land. The future agriculture hub is part of a joint special economic zone launched last year by the two neighbors, expected to cost US$123 million and produce 10,000 tonnes of fresh produce annually. It is attracting Singaporean farmers with promises of cheaper land, labor and energy just over the border.
US actor Matthew McConaughey has filed recordings of his image and voice with US patent authorities to protect them from unauthorized usage by artificial intelligence (AI) platforms, a representative said earlier this week. Several video clips and audio recordings were registered by the commercial arm of the Just Keep Livin’ Foundation, a non-profit created by the Oscar-winning actor and his wife, Camila, according to the US Patent and Trademark Office database. Many artists are increasingly concerned about the uncontrolled use of their image via generative AI since the rollout of ChatGPT and other AI-powered tools. Several US states have adopted
A proposed billionaires’ tax in California has ignited a political uproar in Silicon Valley, with tech titans threatening to leave the state while California Governor Gavin Newsom of the Democratic Party maneuvers to defeat a levy that he fears would lead to an exodus of wealth. A technology mecca, California has more billionaires than any other US state — a few hundred, by some estimates. About half its personal income tax revenue, a financial backbone in the nearly US$350 billion budget, comes from the top 1 percent of earners. A large healthcare union is attempting to place a proposal before
KEEPING UP: The acquisition of a cleanroom in Taiwan would enable Micron to increase production in a market where demand continues to outpace supply, a Micron official said Micron Technology Inc has signed a letter of intent to buy a fabrication site in Taiwan from Powerchip Semiconductor Manufacturing Corp (力積電) for US$1.8 billion to expand its production of memory chips. Micron would take control of the P5 site in Miaoli County’s Tongluo Township (銅鑼) and plans to ramp up DRAM production in phases after the transaction closes in the second quarter, the company said in a statement on Saturday. The acquisition includes an existing 12 inch fab cleanroom of 27,871m2 and would further position Micron to address growing global demand for memory solutions, the company said. Micron expects the transaction to
RSS